SCHEMBL26101362

SCHEMBL26101362

CCOC(=O)c1nsc(C)c1I

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.44
▸ LMNA P02545 3/20 0.44
▸ GAA P10253 2/20 0.44
▸ TSHR P16473 2/20 0.43
▸ ALDH1A1 P00352 6/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ TP53 P04637 1/20 0.39
▸ PDE4A P27815 1/20 0.39
▸ FHIT P49789 1/20 0.39
▸ ILK Q13418 1/20 0.38
▸ MAPT P10636 5/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ HPGD P15428 4/20 0.38
▸ PKM P14618 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ CCR6 P51684 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26926858 0.81 NPSR1 (0.45) KDM4ELMNAGAATSHRALDH1A1
SCHEMBL23596008 0.79 RAB9A (0.48) KDM4ELMNATSHRALDH1A1MEN1
SCHEMBL22609200 0.79 GAA (0.44) KDM4ELMNAGAATSHRALDH1A1
SCHEMBL22609240 0.79 ALDH1A1 (0.50) KDM4ELMNAGAATSHRALDH1A1
SCHEMBL26927303 0.75 LDHA (0.34) ALDH1A1CYP1A2MAPTHSD17B10
SCHEMBL22609216 0.73 GAA (0.44) KDM4ELMNAGAATSHRALDH1A1
SCHEMBL12410905 0.71 GAA (0.55) KDM4ELMNAGAAALDH1A1CYP1A2
SCHEMBL7794327 0.70 TSHR (0.61) KDM4ELMNAGAATSHRALDH1A1
SCHEMBL4699036 0.70 TSHR (0.42) KDM4ELMNAGAATSHRALDH1A1
SCHEMBL9477027 0.70 ALDH1A1 (0.61) KDM4ELMNAGAATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132127-A1 NOVEL SPIRO COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2026-05-14 — — US disclosed
CN-118176179-A Novel spiro compounds 田边三菱制药株式会社 2024-06-11 — — CN disclosed
WO-2023074847-A1 NOVEL SPIRO COMPOUND 田辺三菱製薬株式会社 2023-05-04 — — WO disclosed
WO-2023074847-A1 NOVEL SPIRO COMPOUND 田辺三菱製薬株式会社 2023-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132127-A1 NOVEL SPIRO COMPOUND TRHR, NR3C2, THRB KDM4E 4548/4885LMNA 2025/4885GAA 2850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback